• June 17, 2021

Management

Dr. Marc Zabeau, Ph.D. – Founder & Chief Executive Officer

Dr. Zabeau is the co-founder of Methexis Genomics NV. Currently, Dr. Zabeau combines the management of Methexis Genomics with academic responsibilities at the Flanders Interuniversity Institute for Biotechnology (VIB). Marc Zabeau graduated in Zoology at the University of Gent in 1971 and obtained his Ph.D. degree with Prof. J. Schell in 1974 on Escherichia coli genetics. In 1976, he was awarded a Fullbright Hayes postdoctoral fellowship at the Cold Spring Harbor Laboratories (Cold Spring Harbor, NY, USA) and worked with Dr. R. Roberts on type II restriction enzymes.

From 1978 to 1983, he was a research group leader at the European Molecular Biology Laboratory in Heidelberg (Germany), where he developed recombinant DNA technologies for overexpressing genes. In 1983, he moved from academic research to industry to head the research at Plant Genetic Systems N.V. (Gent, Belgium), where his team was to first to successfully engineer insect resistance in plants. In 1988, he first set up a biotechnology consulting firm, and in 1989 started the biotech company KeyGene N.V. in Wageningen (The Netherlands).

There, he invented the AFLP technology which became a most successful tool for positional cloning and marker-assisted selection. In 1995, he created GenScope Inc. to apply AFLP to genome-wide transcript profiling for pharmaceutical applications, a company that was acquired two years later by Perkin Elmer Inc. He directed PE GenScope until 1998. In October 1999, he returned to academia, to become Scientific Director of the Department of Plant Genetics at the Flanders Interuniversity Institute for Biotechnology (VIB), University of Gent.

After refocusing the departmental research and organization towards a systems biology approach he took up the position of Director of Strategic Planning. In this period he actively promoted European Plant Science, and plant genomics in particular, as Chairman of the European Plant Science Organization (EPSO).

Dr. Patrick Stanssens, Ph.D. – Founder & Chief Operating Officer

Dr. Stanssens is the co-founder of Methexis Genomics NV. He has been working in the genomics field since 1996; at GenScope (Wageningen, The Netherlands) and, following its acquisition, at Applera – Applied Biosystems, he developed the use of the AFLP fingerprinting technique for expression profiling. In the period from 1984 to 1995 he occupied various managerial R&D; positions at Plant Genetic Systems NV (Ghent, Belgium; now part of Bayer) and, later, the biopharmaceutical company Corvas International Inc. (San Diego, CA; recently acquired by Dendreon).

At Corvus, he co-developed an injectable anticoagulant that is currently advanced into phase III clinical testing. At PGS he conceived the use of ribonucleases to engineer ‘nuclear male sterility’ which eventually resulted in a proprietary pollination control system for crop hybridization (SeedLink®). Patrick Stanssens also worked at interim for Virco NV (Mechelen, Belgium) on the development of their HIV resistance monitoring system. He obtained his Ph.D. from the Laboratory Molecular Biology of Prof. W. Fiers (University of Ghent, Belgium).

Luc Dochez, MBA – Sales, Marketing & Business Development Manager

Luc Dochez is the Sales, Marketing & Business Development Manager of the company, responsible for all commercial activities as well as financial operations at Methexis Genomics. Prior to joining Methexis Genomics, Mr. Dochez was a business consultant at Arthur D. Little’s Healthcare Practice in Brussels, focusing on the biotechnology industry. While working at Arthur D.

Little, Mr. Dochez was engaged in a variety of projects, ranging from strategy development, due diligence, business planning, cost optimization to supply chain optimization. Mr. Dochez is a pharmacist from the Katholieke Universiteit Leuven. He also obtained a postgraduate in Business Economics from the Katholieke Universiteit Leuven and an MBA from the Vlerick Leuven Ghent Management School.

Paul Kiefer – Senior Business Consultant

Paul Kiefer is president of P. J. Kiefer and Associates, St. Louis, Missouri, a consulting firm specializing in business development and technology transfer in the area of molecular biology as applied to agriculture and human health. The firm has assisted clients in North America, Western Europe, India, and Egypt. Mr. Kiefer received a B. S. degree with a major in Organic Chemistry from the University of Dayton, Dayton, Ohio.

He joined Monsanto Research Corporation in Dayton and held a number of positions in technical product development, planning, and program management. Mr. Kiefer accepted a transfer to Monsanto’s Agricultural Company in St. Louis, Missouri, and assumed progressively responsible positions, including Product Management and Corporate Planning. Mr. Kiefer assumed responsibility for the commercial development of Monsanto’s molecular biology and plant sciences technologies, which resulted in a worldwide leadership position for Monsanto.